• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4612198)   Today's Articles (1188)   Subscriber (49383)
For: Van Laethem JL, Borbath I, Prenen H, Geboes KP, Lambert A, Mitry E, Cassier PA, Blanc JF, Pilla L, Batlle JF, Garrote MR, Pazo-Cid RA, Gallego I, Smith KE, Ellmark P, Pico de Coaña Y, Ambarkhane SV, Macarulla T. Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study. Lancet Oncol 2024;25:853-864. [PMID: 38834087 DOI: 10.1016/s1470-2045(24)00263-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2024] [Revised: 05/01/2024] [Accepted: 05/02/2024] [Indexed: 06/06/2024]
Number Cited by Other Article(s)
1
Pathak P, Weekes C, Wo JY. Small steps can lead to substantial breakthroughs: moving the therapeutic needle forward in pancreatic cancer. Lancet Oncol 2024;25:824-825. [PMID: 38834088 DOI: 10.1016/s1470-2045(24)00290-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2024] [Revised: 05/17/2024] [Accepted: 05/17/2024] [Indexed: 06/06/2024]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA